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ABSTRACT
Antituberculosis drug isoniazid (INH) and hydrazine (HZ) have been determined by capillary column gas chromatography
after precolumn derivatization with trifluoroacetylacetone (FAA). Phenylhydrazine (PHZ) when present together with INH and
HZ also separated completely from the column HP‑5 (30 mm × 0.32 mm I.D) connected with flame ionization detection (FID), and
thus was used as an internal standard. The linear calibration ranges for INH and HZ were determined to be 2.5-25 μg/mL and 2.521.2 μg/mL respectively, with detection limit (S/N = 3) corresponding 62.5 pg reaching to the detector. The method was applied
for the determination of INH and HZ from pharmaceutical preparations. The method was also used for determination of INH from
blood of tuberculosis patient. The amount of INH found in the blood serum of tuberculosis patients on chemotherapy with INH
based drugs was within 0.82‑4.8 μg/mL with relative standard deviation (RSD) of 2-5.8%. The recovery percentage of INH from
blood samples was found 98% with RSD 2.5%.
Key words: Isoniazid, Hydrazine, Trifluoroacetylacetone, Capillary gas chromatographic determination

INTRODUCTION
INH (isonicotinoylhydrazine) is the most potent and
selective tuberculostatic antibacterial agent in the therapy
of tuberculosis(1). It inhibits the growth of Tubercle bacillus in vitro in concentration less than 1 μg/mL(2). It is also
used as a propylactic agent for persons constantly exposed
to tubercular patients. INH gains access to all organs
and all body fluids including cerebrospinal fluids and this
character renders the drug of special value in treating
tuberculosis meningitis and other extra pulmonary forms
of the disease. When used alone, it is at least equal to
streptomycin in the therapy of tuberculosis. It is believed
to affect lipids, nucleic acids, and glycolysis or mycolic
acid biosynthesis (3). HZ is toxic substance and may be
present in INH tablets as the decomposition product (4).
Various analytical techniques such as titrimetry (5),
spectrophotometry (6‑8) , spectro-f luorimetry (9) , atomic
absorption (10), chemiluminescence (11), electroanalytical
techniques (12-13), kinetic determination (14), f low injec‑
tion(14,16), thin layer chromatography(17-18), capillary elec‑
trophoresis (19-20) and liquid chromatography (21‑24) have
been used for the quantitation of INH in pharmaceutical
preparations and biological samples. The liquid chro‑
matography with UV detection is carried out either by
measuring the natural absorbance of INH at 263 nm or
by precolumn derivatization with a suitable derivatizing
reagent(25‑27). The determination limits for INH has been
reported within 0.5-8.0 μg/mL(24). The gas chromatogra‑
* Author for correspondence. Tel: +92-222-772704;
Fax: +92-222-771372; E-mail: liaquat_zardari@yahoo.com

phy (GC) of INH was carried out after derivatization with
trifluoroacetic anhydride or bis(trimethylsilyl)trifluoroac
etamide and quantitation was carried by mass spectrom‑
etry(28-29). The use of acid anhydride affected the perfor‑
mance of GC column. β-diketone reacted with amino
compounds to form Schiff bases and addition of carbon
chain could enhance FID sensitivity. FAA has been used
for GC determination of putresine and cadverine from
biological fluids(30).
The present work examines GC determination of
INH and HZ after derivatization with FAA using PHZ
as an internal standard. The volatile derivatives are easy
to elute and separate from capillary GC column with
required sensitivity for the desired application for the
analysis of biological fluids.

MATERIALs AND METHODS
I. Materials and Methods
All the chemicals used were of reagent or pharmaceu‑
tical grade. Freshly prepared double distilled water was
used throughout the study.
Pure INH was obtained from Nabi Qasim Pharma‑
ceuticals, Karachi, Pakistan. HZ (24%), PHZ, FAA and
methanol were purchased from E. Merck, Darmstadt,
Germany. The percentage of HZ in HZ solution was
determined by the titrimetry. Hydrochloric acid (37%),
potassium chloride, acetic acid, sodium acetate, ammo‑
nium acetate, sodium bicarbonate, sodium carbonate,
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ammonium chloride were also obtained from E-Merck
Germany. Buffer solutions in the pH range 1-10 at unit
interval were prepared from hydrochloric acid (0.1 M) and
potassium chloride (1 M) (pH 1 &2), acetic acid (1 M) and
sodium acetate (1 M) (pH 3 to 6); ammonium acetate (pH
7), sodium bicarbonate (1 M) and sodium carbonate (satu‑
rated) (pH 8 & 9), ammonium chloride (1 M) and ammo‑
nia (1 M) (pH 10).
Freshly prepared solution of I N H was used by
dissolving 10.95 mg INH in methanol: water (1:1 v/v) and
final volume was adjusted to 10 mL. FAA (1% v/v) was
prepared in 100 mL of methanol: water (1:1 v/v).
The spectrophotometric studies were carried out
on double beam Hitachi 220 (Hitachi (Pvt) Ltd. Tokyo,
Japan) spectrophotometer with dual 1 cm cells. Gas chro‑
matographic studies were carried out on Agilent model
6890 Net work GC system (Agilent Technologies Inc.
USA) coupled with FID, split/splitless injector operated in
split mode, hydrogen generator (Parker Balston, Analyti‑
cal Gas system H2‑90, Parker Hannifin, Havorhill, MA,
USA) and pure nitrogen (British Oxygen Company, Kara‑
chi). The computer with Chemstation software controlled
the gas chromatograph, and HP LaserJet 1300 printer was
used throughout the study. Capillary column HP‑5 (30
mm × 0.32 mm I.D) with film thickness of 0.25 μm (J &
W scientific GC columns, USA) was used throughout the
study. The Orion model 420A pH meter (Orion Research
Inc, Boston, USA) with glass electrode with combined
reference electrode was used for pH measurements.
II.Gas Chromatographic Determination
The solution (1 m L) cont aining I N H(1‑20 μg),
HZ(1-17 μg) and PHZ(5 μg) was added 1 mL of potas‑
sium chloride-hydrochloric acid buffer pH 2, 1 mL of
(1% v/v) FAA and heated at 75°C for 15 min. The solu‑
tion was cooled at room temperature and were added 1
mL of chloroform. The contents were mixed well and
layers were allowed to separate. Exactly 0.5 mL of chlo‑
roform was pipetted out and transferred to screw capped
vial. The solvent was evaporated under nitrogen gas and
re-dissolved in 0.2 mL of methanol. The solution (1 μL)
was injected on capillary GC column HP‑5 at a column
temperature of 100°C with heating rate 30°C up to 280°C.
The total run time was 7 min and nitrogen flow rate was
1 mL/min. The split ratio was 20:1. The injection port
and detector temperatures were fixed at 200°C and 300°C
respectively. Hydrogen and nitrogen flow rates were fixed
at 40 and 45 mL/min respectively for FID detection.

water (1:1) respectively. The solution was filtered and
final volume was adjusted to 50 mL with methanol:water
(1:1 v/v) respectively. The solution (1 mL) was transferred
to screw-capped vial and 1 mL of chloroform was added.
The contents were mixed well and the layers were allowed
to separate. The aqueous layer was collected. The analyt‑
ical GC procedure II. was then followed after the addition
of 5 µg of PHZ as internal standard.
Ten tablets of INH (Unexo Lab. Ltd, Lahore) were
thoroughly ground and the powder (51.0 mg) was dissolved
in methanol:water (1:1 v/v). The solution was filtered and
the final volume was adjusted to 100 mL. 1 mL was taken
and the analytical procedure II. was followed after the
addition of 5 µg of PHZ as internal standard.
5 mL of well-mixed INH syrup was dissolved in
methanol:water (1:1 v/v), the solution was filtered and
volume was adjusted to 100 mL. The solution was diluted
50 times and 1 mL was processed as analytical procedure
II.. The amounts of INH in pharmaceutical preparations
were evaluated from ratio of the peaks of the analyte and
internal standard and external calibration curve.
IV. Determination of Hydrazine from Isoniazid Formulations
0.5 mL of well-mixed INH syr up containing (5
mg) INH was processed as analytical procedure II.. Ten
tablets of isoniazed were thoroughly ground the powder (1
g, containing 545.5 mg INH) was dissolved in methanol:
water (1:1 v/v) and the solution was filtered and adjusted
to 25 mL. The solution 1 mL was taken and the analytical
procedure II. was followed. The signals corresponding to
HZ and PHZ were recorded.
V. Determination of Isoniazid from Blood Samples
Blood sample (5 mL) of various patients suffer‑
ing from pulmonary tuberculosis was collected 2‑4 hr
after the administration of the drug. The samples were
collected from the patients by vinipuncture with dispos‑
able syringe from Tuberculosis Hospital, Kotri. The blood
samples, was incubated for 1 hr at (30°C) and centrifuged
at 3000 g for 10 min. The supertenant layer was collected
and was added methanol twice in the volume. The mixed
contents were centrifuged at 3000 g for 10 min. The
supertnant was transferred into a vial and 2 mL of chloro‑
form was added. The contents were mixed well and layers
were allowed to separate. The upper layer was pipetted
out into vial and PHZ 5 µg was added. The derivatization
procedure II. then was followed.

III. Determination of Isoniazid in Pharmaceutical Preparations

VI. Recovery of Isoniazid from Blood Samples

Ten tablets of each Remactal, Remister (Novartis
Pharma, Pak. Ltd.) and Myrin P (Leaderle Laboratories
Division, Cyanamid, Pak. Ltd., Karachi) were powdered
and 53.89 mg Remactal, 53.90 mg Remistar and 57.12 mg
Myrin were dissolved in each portions(6 mL) of methanol:

Blood samples (5 mL) collected from a healthy volun‑
teer was processed as above and blood serum was added
INH (6 µg) and processed as above using FAA as deriva‑
tizing reagent. The amount of INH was calculated from
external calibration curve and internal standard.
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RESULTS AND DISCUSSION
INH and HZ were conjugated easily with FAA to
form trif luoroacetylacetone-isonicotinyl hydrazone and
bis(trifluoroacetylacetone) hydrazone (Fiure 1). The pres‑
ence of trifluoromethyl group in FAA could enhance the
volatility and thermal stability of the conjugated. There‑
fore, FAA was selected as the derivatizing reagent for
the selective and sensitive determination of INH and HZ
by capillary column GC. Precolumn derivatization was
carried out, and the elution was executed from the capil‑
lary column HP‑5 at an initial column temperature 100°C
with heating rate 30°C up to 280°C. The run time was 7
min. Nitrogen flow rate was 1 mL/min. Each of the deriv‑
atives INH and HZ gave a single peak with retention time
of 6.5 min and 3.9 min respectively. The derivatives were
separated completely from the derivatizing reagent.
The derivatization conditions were optimized for the
quantitative determination of INH and HZ by measur‑
ing average peak height (n = 3). The effects of pH, the
concentration of derivatizing reagent and reaction time at
70‑80°C were examined. A solution of 1 μL was injected
with split ratio 20:1 and the condition, which gave maxi‑
mum response, was considered optimum.
The pH was varied between 1‑10 at unit interval and
was observed that derivatization occurred in acidic media
(pH 1-3) and a decrease into the response was observed
above pH 3. The optimal response was obtained at pH 2
(Figure 2). The derivatizing reagent concentration was
varied between 1‑3 mL (1% v/v) at an internal of 0.5 mL.
The average peak height (n = 3) was plotted against the
amount of reagent solution added and a similar response
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was obtained at the amount of 1 mL and above, thus 1 mL
was used. Heating time was varied between 5 to 25 min.
at 75°C at an interval of 5 min and same average peak
height (n = 3) was obtained after heating time of 10 to 20
min and 15 min was selected.
Under the same conditions the hydrazino compound:
PHZ was also examined. The compound formed deriva‑
tive with FAA eluted separately (Figure 3) and did not
affect the determination of INH and HZ. PHZ was there‑
fore used as an internal standard.
At the optimized conditions, linear calibration curves
for the simultaneous determination of INH and HZ were
obtained by measuring average peak height (n = 3) with
2.5-25 µg/mL INH and 2.5-21.2 µg/mL HZ with co-effi‑
cient of determination (r2) 0.9806 and 0.9827 respectively
using (n = 5) points calibration. The detection limits
measured as signal to noise ratio 3:1 were obtained with
1.25 μg/mL for INH and HZ corresponding to 62.5 pg
reaching to the detector with split ratio 20:1.
Common additives glucose, magnesium stearate,
gum acacia, talcum, methylparaben, lactose and starch,
when added twice the concentration of INH and HZ, did
not interfere. The method was applied for the determina‑
tion of INH from pharmaceutical preparations: Ramac‑
tal, Remister, Myrin, INH tablets and INH syrup. The
hydrazine was determined from INH tablets and INH
syrup. The GC results are summarized in Table 1 and
2. The INH tablets and INH syrup were analyzed after
dissolution of INH in methanol‑water (1:1 v/v) (Figure
4). The tablets Remactal, Remster and Myrin contained
rifampicin, pyrazinamide and ethambutal together with
INH. INH after derivatization with FAA was extracted in
chloroform and pyrazinamide and ethambutol remained in
aqueous phase and did not interfere the determination of
INH. Rifampicin is extracted in chloroform together with
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Figure 1. Structure diagrams of derivatives with trifluoroacetylac‑
etone (FAA) (a) hydrazine (HZ) (b) isoniazid (INH) (c) phenylhy‑
drazine (PHZ).

Figure 2. Effect of pH on the GC elution of FAA-INH derivative.
GC conditions: The column HP‑5 (30 m × 0.32 mm) with film
thickness 0.25 μm at an initial column temperature 100°C with
heating rate 30°C up to 280°C. The run time was 7 min. Nitrogen
f low rate was 1 mL/min and split ratio 20:1. Injection port and
detector temperatures were 200°C and 300°C. Nitrogen make up
flow rate was 45 mL/min. FID air and hydrogen flow rates were
450 mL and 40 mL respectively.
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Table 1. The determination of isoniazid from pharmaceutical preparations by using FAA as derivatizing reagent
S.NO.

Name of
tablet

Compounds
Present

Amount of
compounds labeled
(mg/tablet)

Amount of Isoniazid
found in mg (RSD%)

%
Relative deviation

1

Remactal

Isoniazid
Rifampicin

150
300

147(8.5)
–

2.0

75
120
400
275

70(7.5)
–
–
–

6.7

Remistar

Isoniazid
Rifampicin
Pyrazinamide
Ethambutanol

Myrin

60
150
400
275

58 (4.0)
–
–
–

3.0

3

Isoniazid
Rifampicin
Pyrazinamide
Ethambutanol

4

Isoniazid
Syrup

Isoniazid

50 mg/5 mL

48mg/5mL
(5.6)

4.0

5

Isoniazid
Tablet

Isoniazid

100

101 (4.5)

1

2

Table 2. Determination of hydrazine from pharmaceutical prepara‑
tions by using FAA as derivatizing reagent

80

Isoniazid syrup

Isoniazid tablet

1 mL contains10mg
of INH

1000 mg of tablets
contain 454.5 mg
INH

70

Amount of INH
labeled in mg

5 µg HZ/18.18 mg of
INH in tablets (2.5)

65

Amount of HZ found
1.0 µg/5 mg of INH
in µg in INH formu‑
syrup (3.2)
lations (RSD%)

Table 3. Analysis of isoniazid from blood samples of T.B meningiti‑
safter chemotherapy with 300 mg of isoniazid using FAA as deriva‑
tizing reagent
Amount of isoniazid
found µg/mL blood
(RSD %) (n = 3)

Patients
No.

Gender

Age

1

Male

38

4.8

(3.2)

2

Male

24

2.5

(5.2)

3

Male

30

2.0

(3.9)

4

Male

40

0.82

(2.0)

5

Female

42

1.0

(5.8)

Peak healght in (pA)

Sample

1

60

3

55

4
2
50

45

40

INH derivative, but did not elute as symmetrical peak,
and disturbed the base line due to on column decomposi‑
tion. However rifampicin separated completely, when
extracted in chloroform prior to derivatization of INH in
aqueous‑methanolic solution and did not affect the deter‑
mination of INH. The relative percentage deviations were
found 1 to 6.7% from the values labeled by the manufac‑
turer with relative standard deviation within 4.0-8.5%
(Table 1) The RSD is slightly on higher side because of the
presence of multi- component system. HZ was checked
for its presence in INH syrup and INH tablets. INH syrup

0

1

2

3

4

5

6

7

Retention time in (min)

Figure 3. GC separation of (1) solvent & FAA (2) HZ (3) PHZ (4)
INH as derivative of FAA. GC conditions as Figure 2.

containing 5 mg of INH and INH tablets containing 18.18
mg INH were analyzed for HZ and PHZ was added as
internal standard. The signals corresponding to HZ, and
PHZ were recorded. The Table 2 indicated the presence
of 1.0 µg HZ/5 mg INH in INH syrup and 5 µg HZ/18.18
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amount of INH recovered was evaluated from calibration
curve. The amount of recovery was 98% with RSD 2.5%.
(Figure 5)

1

80

70

CONCLUSIONS
Simple GC procedure has been developed for the
determination of INH from pharmaceutical preparations
and blood samples after precolumn derivatization with
FAA. HZ was also determined from INH formulations
and PHZ was as internal standard. The detection limits
were obtained at 62.5 pg reaching to the detector. The
analysis of pharmaceutical preparations and blood samples
after chemotherapy were observed with RSD 3.2-5.8%.
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